Both in Pharmaceuticals
Rigel Pharmaceuticals Inc. (New) vs Syndax Pharmaceuticals
Over the past year RIGL returned +80.7% and SNDX returned −31.9%; their daily moves had a correlation of 0.23.
RIGL +80.7% SNDX −31.9%Growth of $1, one year, split-adjusted
| Metric | RIGL | SNDX |
|---|---|---|
| Price | $51.29 | $10.45 |
| Market cap | $958.1M | $933.2M |
| Today | +4.97% | −26.87% |
| 1 month | +11.2% | −39.8% |
| 6 months | +92.3% | −49.4% |
| Year to date | +19.8% | −50.3% |
| 1 year | +67.3% | −24.1% |
| Revenue growth (YoY) | −22.6% | +81.6% |
| Gross margin | 89.2% | 83.2% |
| Net margin | 22.0% | −59.3% |
| P/E (TTM) | 3.0× | — |
| Price / sales | 3.5× | 3.2× |
| Net cash | $56.1M | $182.3M |
| Dividend yield | — | — |
| Volatility (60d) | 37.8% | 84.0% |
| Short % of float | 16.3% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).